Erratum: Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis: Erratum

No authors listed

Published Erratum

No authors listed. Medicine (Baltimore). 2017.

. 2017 Jul 28;96(30):e7724.

doi: 10.1097/MD.0000000000007724. eCollection 2017 Jul.

Abstract

[This corrects the article DOI: 10.1097/MD.0000000000007422.].

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
Roh TH, Park HH, Kang SG, Moon JH, Kim EH, Hong CK, Ahn SS, Choi HJ, Cho J, Kim SH, Lee SK, Kim DS, Kim SH, Suh CO, Lee KS, Chang JH. Roh TH, et al. Medicine (Baltimore). 2017 Jul;96(27):e7422. doi: 10.1097/MD.0000000000007422. Medicine (Baltimore). 2017. PMID: 28682902 Free PMC article.

1. Roh T-H, Park H-H, Kang S-G. Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis. Medicine. 2017. 96:e7422. - PMC - PubMed